"The healthiest business on the U.S. stock market"
Motley Fool Money
Pharma Finances: COVID-19 and Beyond
This chapter examines the financial maneuvers of Abbott Laboratories, Moderna, and Pfizer in the wake of COVID-19 sales revenues. It highlights their investments in research and development, innovative drug pipelines, and strategic focuses on various diseases, while assessing which company is likely to maximize its growth potential.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
